Summary
Machine-generated summaryThe National Institute of Oncology in Hungary seeks to lease a high-performance sequencing device for its Department of Molecular Genetics and Molecular Pathology departments for 24 months. The winner must deliver and install the device, provide reagents and validation testing, a 2-working-day trial run, training for 5 people, and service during the lease. The device must process 9,000 samples plus 30% per year within a maximum of 14 calendar days from sampling to report, and support WGS, WES, liquid biopsy profiling of over 500 genes, RNA-seq, single-cell, spatial and multi-omics, methylation and proteomics analyses.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile5 open tenders right now
- Dressings; wound closure, suturing and vessel ligation supplies - Dressings and surgical sets 2026 20 days left
- Contrast agents for the National Institute of Oncology in 3 lots 26 days left
- Magyarország - Infúziós kellékek - Zárt rendszerű infúziókészítő eszközök 29 days left
Recent awards
Similar tenders
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €11,367,580
- Buyer track record on Aperlena
- 21 notices tracked · 7 awarded
- €2,881,917 in awarded contracts
Never miss a tender like this
23 new notices in Medical equipment & pharmaceuticals in Hungary in the last 7 days. Get an email when new ones appear. Free.
Set up my alert